Product Name :
BVT948
Description:
BVT948 is a protein tyrosine phosphatase (PTP) inhibitor which can also inhibit several cytochrome P450 (P450) isoforms and lysine methyltransferase SETD8 (KMT5A).
CAS:
39674-97-0
Molecular Weight:
241.24
Formula:
C14H11NO3
Chemical Name:
3,3-dimethyl-1H,2H,3H,4H,5H-benzo[g]indole-2,4,5-trione
Smiles :
CC1(C)C2=C(NC1=O)C1=CC=CC=C1C(=O)C2=O
InChiKey:
LLPBUXODFQZPFH-UHFFFAOYSA-N
InChi :
InChI=1S/C14H11NO3/c1-14(2)9-10(15-13(14)18)7-5-3-4-6-8(7)11(16)12(9)17/h3-6H,1-2H3,(H,15,18)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Apraglutide} medchemexpress|{Apraglutide} GPCR/G Protein|{Apraglutide} Protocol|{Apraglutide} Data Sheet|{Apraglutide} custom synthesis|{Apraglutide} Cancer}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
BVT948 is a protein tyrosine phosphatase (PTP) inhibitor which can also inhibit several cytochrome P450 (P450) isoforms and lysine methyltransferase SETD8 (KMT5A).|Product information|CAS Number: 39674-97-0|Molecular Weight: 241.24|Formula: C14H11NO3|Chemical Name: 3,3-dimethyl-1H,2H,3H,4H,5H-benzo[g]indole-2,4,5-trione|Smiles: CC1(C)C2=C(NC1=O)C1=CC=CC=C1C(=O)C2=O|InChiKey: LLPBUXODFQZPFH-UHFFFAOYSA-N|InChi: InChI=1S/C14H11NO3/c1-14(2)9-10(15-13(14)18)7-5-3-4-6-8(7)11(16)12(9)17/h3-6H,1-2H3,(H,15,18)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 100 mg/mL (414.52 mM; Need ultrasonic).{{DPN} site|{DPN} Apoptosis|{DPN} Protocol|{DPN} Description|{DPN} custom synthesis|{DPN} Autophagy} |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Results show that the effect of BVT948 (BVT.PMID:26760947 948) is to strengthen the insulin signal and has no effects on the duration of the signal. BVT948 appears to be an effective inhibitor of both protein tyrosine phosphatases (PTP activity and P450 activity). BVT948 efficiently and selectively suppresses cellular H4 lysine 20 (H4K20me1) at doses lower than 5 μM within 24 h. The cells treated with BVT948 recapitulate cell-cycle-arrest phenotypes similar to what are reported for knocking down SETD8 by RNAi. Treatment of MCF-7 cells with 0.5, 1 or 5 μM of BVT948 for 24 h does not cause any significant changes in cell viability. BVT948 inhibits TPA-induced MMP-9 up-regulation in a dose-dependent manner. Treatment with BVT948 inhibits TPA-stimulated NF-κB binding activity, but not AP-1 binding activity. BVT948 does not affect the MAPK phosphorylation by TPA. Treatment with BVT948 diminishes the TPA-induced cell invasion by 50%.|In Vivo:|Results show that 3 μmol/kg BVT948 (BVT.948) significantly enhances glucose clearance from the blood stream in response to insulin compare with vehicle-treated controls.|Products are for research use only. Not for human use.|